Clinical Efficacy and Safety of Carvedilol Combined with Pancreatopeptidase Injection in the Treatment of Type 2 Diabetic Nephropathy Complicated with Hypertension
LI Qian, SU Hang
Department of Nephrology, Xianyang Hospital, Yan 'an University, Xianyang Shaanxi 712000
Abstract 【Objective】To investigate the clinical efficacy and safety of carvedilol combined with pancreatopeptidase injection in the treatment of type 2 diabetic nephropathy with hypertension. 【Methods】A total of 94 patients with type 2 diabetic nephropathy complicated with hypertension were randomly divided into two groups, with 47 cases in each group. All patients received routine treatment. On this basis, the control group was treated with carvedilol, and the observation group was treated with carvedilol combined with pancreatopeptidase injection for 3 months. Blood glucose, blood pressure, renal function, renal artery hemodynamics, clinical efficacy and adverse reactions were observed before and after treatment in two groups. 【Results】(1)The total effective rate of treatment in the observation group was significantly higher than that in the control group (78.72% vs 59.57%,P<0.05). (2) The blood pressure and glucose of the two groups after treatment were lower than those before treatment (P<0.05). There were no significant differences in FPG, 2hPG, SBP and DBP between the two groups before and after treatment (P>0.05).(3)After treatment, BUN, SCr, GFR, UAER and UAlb decreased in both groups, and the extent of decrease in the observation group was greater than that in the control group (P<0.05).(4)After treatment, RI of the two groups decreased significantly, the peak velocity of renal artery systolic velocity (Vmax)and the end diastolic velocity of renal artery (Vmin) increased significantly; and these increase in the observation group were larger than that those in the control group (P<0.05).(5)There was no significant difference in the incidence of adverse reactions between the two groups (P<0.05). 【Conclusion】Carvedilol combined with pancreatopeptidase injection is more effective in the treatment of type 2 diabetic nephropathy complicated with hypertension. It can significantly reduce blood glucose and blood pressure, improve the renal function and hemodynamics of both kidneys, and is safe and effective.
LI Qian,SU Hang. Clinical Efficacy and Safety of Carvedilol Combined with Pancreatopeptidase Injection in the Treatment of Type 2 Diabetic Nephropathy Complicated with Hypertension[J]. JOURNAL OF CLINICAL RESEARCH, 2021, 38(1): 81-81.
2021, Vol. 38 
